SCHEMBL26415845

SCHEMBL26415845

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5cccc6oc7cc(-n8c9ccccc9c9cc%10ccccc%10cc98)ccc7c56)cc4)n3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.32
PTGER4 P35408 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ATM Q13315 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALK Q9UM73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415839 0.99 BACE1 (0.32) BACE1PTGER4KDM4EATML3MBTL1
SCHEMBL21863023 0.96 PTGER4 (0.31) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL26415822 0.96 PTGER4 (0.31) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL26415840 0.95 HCRTR1 (0.33) BACE1KDM4EATML3MBTL1ALDH1A1
SCHEMBL21863024 0.94 PTGER4 (0.32) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL25954868 0.94 BACE1 (0.33) BACE1PTGER4KDM4EATML3MBTL1
SCHEMBL25954874 0.94 BACE1 (0.33) BACE1PTGER4KDM4EATML3MBTL1
SCHEMBL21862741 0.93 ALDH1A1 (0.32) PTGER4KDM4EALDH1A1TP53MAPT
SCHEMBL26416811 0.93 HCRTR1 (0.33) BACE1KDM4EATML3MBTL1ALDH1A1
SCHEMBL23204107 0.93 PTGER4 (0.34) PTGER4KDM4EATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 BACE1 239/4885PTGER4 867/4885KDM4E 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.